| 英文名称 |
中文名称 |
CAS号 |
操作 |
| JH-VIII-157-02 |
化合物 T15612 |
1639422-97-1 |
详细
|
| PRN1008 |
瑞扎布鲁替尼 |
1575596-29-0 |
详细
|
| ARQ 531 |
ARQ-531 |
2095393-15-8 |
详细
|
| TIE-2/VEGFR-2 kinase-IN-1 |
6-(4-甲氧基苯基)呋喃并[2,3-D]嘧啶-4-胺 |
453590-24-4 |
详细
|
| Pralsetinib |
BLU-667（拉西替尼） |
2097132-94-8 |
详细
|
| trans-Pralsetinib |
cis-Pralsetinib hydrochloride (cis-BLU-667 hydrochloride) |
2097132-93-7 |
详细
|
| cFMS Receptor Inhibitor II |
CFMS RECEPTOR INHIBITOR II |
959860-85-6 |
详细
|
| AGL-2263 |
AG 2263 |
638213-98-6 |
详细
|
| AZD3229 Tosylate |
AZD3229 Tosylate |
2248003-71-4 |
详细
|
| TL02-59 |
3-(6,7-dimethoxyquinazolin-4-yloxy)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-4-methylbenzamide |
1315330-17-6 |
详细
|
| WRG-28 |
WRG-28 |
1913291-02-7 |
详细
|
| FGFR1/DDR2 inhibitor 1 |
FGFR1/DDR2 inhibitor 1 |
2308497-58-5 |
详细
|
| SRI 31215 TFA |
SRI-31215 BIS-TFA SALT |
1832686-44-8 |
详细
|
| CLK-IN-T3 |
CLK inhibitor T3
(T3) |
2109805-56-1 |
详细
|
| MAZ51 |
CS-2885 |
163655-37-6 |
详细
|
| AZD7507 |
CS-2850 |
1041852-85-0 |
详细
|
| AZ-Dyrk1B-33 |
3-(2-Methyl-4-pyrimidinyl)-1-(phenylmethyl)-1H-pyrrolo[2,3-c]pyridine |
1679330-37-0 |
详细
|
| RU-301 |
RU-301 |
1110873-99-8 |
详细
|
| Tyrphostin AG1433 |
Tyrphostin AG1433 |
168835-90-3 |
详细
|
| Pazopanib Hydrochloride |
盐酸帕唑帕尼 |
635702-64-6 |
详细
|
| PF-04217903 methanesulfonate |
PF 04217903 MESYLATE |
956906-93-7 |
详细
|
| Lyn-IN-1 |
巴非替尼 |
887650-05-7 |
详细
|
| Cabozantinib S-malate |
苹果酸卡博替尼 |
1140909-48-3 |
详细
|
| Pivanex |
(2,2-二甲基-1-氧代丙氧基)丁酸甲酯 |
122110-53-6 |
详细
|
| R406 |
6-[[5-氟-2-[(3,4,5-三甲氧基苯基)氨基]-4-嘧啶基]氨基]-2,2-二甲基-2H-吡啶并[3,2-B]-1,4-恶嗪-3(4H)-酮苯磺酸盐 |
841290-81-1 |
详细
|
| DPH |
5-(3-(4-氟苯基)-1-苯基-1H-吡唑-4-基)咪唑烷-2,4-二酮 |
484049-04-9 |
详细
|
| Lck Inhibitor |
6-(2,6-二甲基苯基)-2-[[4-(4-甲基-1-哌嗪基)苯基]氨基]-嘧啶并[5',4':5,6]嘧啶并[1,2-A]苯并咪唑-5(6H)-酮 |
847950-09-8 |
详细
|
| UNC2025 hydrochloride |
UNC2025 盐酸盐 |
2070015-17-5 |
详细
|
| TAS-115 mesylate |
TAS-115 MESYLATE |
1688673-09-7 |
详细
|
| Gilteritinib hemifumarate |
GILTERITINIB FUMARATE |
1254053-84-3 |
详细
|
| BT-13 |
BT-13 |
924537-98-4 |
详细
|
| Y15 |
1,2,4,5-苯四胺四盐酸盐 |
4506-66-5 |
详细
|
| Bozitinib |
BOZITINIB (PLB-1001) |
1440964-89-5 |
详细
|
| Hck-IN-1 |
Nef-IN-B9 |
1473404-51-1 |
详细
|
| UNC2541 |
UNC2541 |
1612782-86-1 |
详细
|
| TAM-IN-2 |
TAM-IN-2 |
2135642-56-5 |
详细
|
| Petunidin chloride |
矮牵牛素PT |
1429-30-7 |
详细
|
| Syk-IN-1 |
1,2,4-Triazine-6-carboxamide, 3-[[(1R,2S)-2-aminocyclohexyl]amino]-5-(1H-indol-7-ylamino)- |
1491150-77-6 |
详细
|
| PRN694 |
1575818-46-0 |
1575818-46-0 |
详细
|
| Mirk-IN-1 |
1386979-55-0 |
1386979-55-0 |
详细
|
| Brigatinib |
布格替尼 |
1197953-54-0 |
详细
|
| Remibrutinib |
LOU-064 |
1787294-07-8 |
详细
|
| Orelabrutinib |
奥布替尼 |
1655504-04-3 |
详细
|
| SKLB4771 |
FLT3-IN-1 |
1370256-78-2 |
详细
|
| Ibrutinib-biotin |
1599432-18-4 |
1599432-18-4 |
详细
|
| SU4312 |
SU 4312;NSC 86429;SU-4312;NSC-86429 |
5812-07-7 |
详细
|
| tBID |
1639895-85-4 |
1639895-85-4 |
详细
|
| Rp-cAMPS triethylammonium salt |
ADENOSINE 3',5'-CYCLIC MONOPHOSPHOROTHIOATE, RP-ISOMER, TRIETHYLAMMONIUM SALT |
151837-09-1 |
详细
|
| Rp-cAMPS sodium salt |
ADENOSINE-3',5'-CYCLIC MONOPHOSPHOROTHIOATE, RP-ISOMER SODIUM SALT |
142439-94-9 |
详细
|
| BPR1K871 |
1-(3-氯苯基)-3-(5-(2-((7-(3-(二甲基氨基)丙氧基)喹唑啉-4-基)氨基)乙基)噻唑-2-基)脲 |
2443767-35-7 |
详细
|
| TAK-659 hydrochloride |
TAK-659 (HYDROCHLORIDE) |
1952251-28-3 |
详细
|
| CHMFL-BMX-078 |
化合物CHMFL-BMX-078 |
1808288-51-8 |
详细
|
| (±)-Zanubrutinib |
(±)-赞鲁替尼 |
1633350-06-7 |
详细
|
| Bosutinib |
伯舒替尼 |
380843-75-4 |
详细
|
| Nilotinib |
尼罗替尼 |
641571-10-0 |
详细
|
| Btk inhibitor 2 |
Btk inhibitor 2 |
1558036-85-3 |
详细
|
| CSF1R-IN-1 |
CSF1R-IN-1 |
2095849-04-8 |
详细
|
| BMS-935177 |
1231889-53-4 |
1231889-53-4 |
详细
|
| Dasatinib hydrochloride |
达沙替尼盐酸盐 |
854001-07-3 |
详细
|
| TG 100572 Hydrochloride |
4-氯-3-[5-甲基-3-[[4-[2-(1-吡咯烷基)乙氧基]苯基]氨基]-1,2,4-苯并三嗪-7-基]苯酚单盐酸盐 |
867331-64-4 |
详细
|
| AG 1295 |
酪氨酸磷酸化抑制剂AG1295 |
71897-07-9 |
详细
|
| Dovitinib lactate |
多韦替尼乳酸盐 |
692737-80-7 |
详细
|
| Masitinib mesylate |
马赛替尼 |
1048007-93-7 |
详细
|
| Motesanib |
莫特塞尼 |
453562-69-1 |
详细
|
| Sunitinib Malate |
苹果酸舒尼替尼 |
341031-54-7 |
详细
|
| Sunitinib |
舒尼替尼 |
557795-19-4 |
详细
|
| Vandetanib |
凡德他尼 |
443913-73-3 |
详细
|
| Multi-kinase inhibitor 1 |
化合物MULTI-KINASE INHIBITOR I |
778274-97-8 |
详细
|
| PD173074 |
PD173074 |
219580-11-7 |
详细
|
| Toceranib phosphate |
托西尼布磷酸盐 |
874819-74-6 |
详细
|
| Tirbanibulin dihydrochloride |
5-[4-[2-(4-吗啉基)乙氧基]苯基]-N-(苯基甲基)-2-吡啶乙酰胺盐酸盐 |
1038395-65-1 |
详细
|
| Tirbanibulin Mesylate |
1080645-95-9 |
1080645-95-9 |
详细
|
| Ensartinib hydrochloride |
2137030-98-7 |
2137030-98-7 |
详细
|
| Tyrosine kinase inhibitor |
DCL000409(XL184) |
1021950-26-4 |
详细
|
| PF-573228 |
6-[(4-((3-(甲磺酰基)苄基)氨基)-5-三氟甲基嘧啶-2-基)氨基]-3,4-二氢-1H-喹啉-2-酮 |
869288-64-2 |
详细
|
| SU14813 maleate |
5-[(Z)-(5-氟-1,2-二氢-2-氧代-3H-吲哚-3-亚基)甲基]-N-[(2S)-2-羟基-3-(4-吗啉基)丙基]-2,4-二甲基-1H-吡咯-3-甲酰胺马来酸盐 |
849643-15-8 |
详细
|
| Lck inhibitor 2 |
3-[[4-[(5-羟基-2-甲基苯基)氨基]-2-嘧啶基]氨基]苯甲酰胺 |
944795-06-6 |
详细
|
| Osteogenic Growth Peptide (10-14) |
OSTEOGENIC GROWTH PEPTIDE (10-14) |
105250-85-9 |
详细
|
| Ningetinib Tosylate |
对甲苯磺酸宁格替尼 |
1394820-77-9 |
详细
|
| 3-Hydroxy Midostaurin |
CGP52421 |
179237-49-1 |
详细
|
| INDY |
INDY |
1169755-45-6 |
详细
|
| KB SRC 4 |
1-[3-[1-([1,1'-Biphenyl]-3-ylMethyl)-1H-1,2,3-triazol-5-yl]phenyl]-3-(4-chlorophenyl)-1H-pyrazolo[3,4-d]pyriMidin-4-aMine |
1380088-03-8 |
详细
|
| SU16f |
化合物 T16947 |
251356-45-3 |
详细
|
| PF-06465469 |
PF 06465469
Discontinued See A191400 |
1407966-77-1 |
详细
|
| Vorolanib |
VOROLANIB |
1013920-15-4 |
详细
|
| Acrizanib |
化合物ACRIZANIB |
1229453-99-9 |
详细
|
| Vecabrutinib |
维卡布鲁替尼 |
1510829-06-7 |
详细
|
| Conteltinib |
CONTELTINIB (CT-707) |
1384860-29-0 |
详细
|
| Lanraplenib succinate |
Lanraplenib (succinate) |
1800047-00-0 |
详细
|
| Tivozanib |
替沃扎尼 |
475108-18-0 |
详细
|
| ENMD-2076 |
6-(4-甲基-1-哌嗪基)-N-(5-甲基-1H-吡唑-3-基)-2-[(1E)-2-苯乙烯基]-4-嘧啶胺 |
934353-76-1 |
详细
|
| Ibrutinib D5 |
伊布替尼布D5 |
1553977-17-5 |
详细
|
| A-770041 |
A-770041 |
869748-10-7 |
详细
|
| SPP-86 |
1-(1-Methylethyl)-3-(2-phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
1357349-91-7 |
详细
|
| BMS-509744 |
N-(5-((5-(4-乙酰基哌嗪-1-甲酰基)-4-甲氧基-2-甲基苯基)硫基)噻唑-2-基)-4-(((3,3-二甲基丁烷-2-基)氨基)甲基)苯甲酰胺 |
439575-02-7 |
详细
|
| JNJ-38877618 |
JNJ-38877618 |
943540-74-7 |
详细
|
| FN-1501 |
1429515-59-2 |
1429515-59-2 |
详细
|
| PDGFRα kinase inhibitor 1 |
PDGFRα kinase inhibitor 1 |
2209053-93-8 |
详细
|
| Jaspamycin |
JASPAMYCIN |
22242-96-2 |
详细
|
| Nintedanib Ethanesulfonate Salt |
尼达尼布乙磺酸盐 |
656247-18-6 |
详细
|